
Actionable equity research, rigorous valuation models, and a transparent tracking portfolio.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 71 | Founded | a year ago | Last Issue | 6 days ago |
| Active | |||||

If you ask the average person on the street about GameStop, they will likely talk about 2021. They’ll mention “Roaring Kitty,” diamond hands, the short squeeze that nearly bankrupted Wall...
E-commerce brands are desperate for an alternative to Meta and Google. AppLovin's pure-play transition and new self-serve AI engine just unlocked a $600B+ market. Dive into the fundamental thesis and our proprietary DCF modeling a $1,000+ p...
For the better part of the last decade, the narrative surrounding Oracle was stagnant. The broader technology world viewed the company as a legacy dinosaur—a ruthless, sales-driven monopoly that extract...
Merging deep fundamental equity research with the aggressive swing trading psychology you need to survive the 2026 market.
In this interview, I sit down with Dave Gretta—a former Wall Street professional, 30-year data analyst, and author o...
Breaking down the base cases, the bull cases, and the 5-year compounding thesis that could sky rocket Take-Two towards $600 per share.
It is difficult to overstate the cultural gravity of Grand Theft Auto VI. For over a decade, fans have d...
Subscribers, engagement, traffic and sponsorship for CompoundingAlpha.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Fundamental equity research driven by rigorous hours of digging through SEC filings and DCF modeling. 32.8% CAGR since '22.
Published stock investing book author (Across The Street From Wall Street) writes about stock investing and options/swing trading. Some travel and mindset posts too.
Tracking biotech & Banking acquisition targets Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"
You can find recent issues that have been published by CompoundingAlpha on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to CompoundingAlpha, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch CompoundingAlpha as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact CompoundingAlpha using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like CompoundingAlpha. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.